Status:
UNKNOWN
Major Cations Targeted Fluid Therapy In Renal Transplantation.
Lead Sponsor:
Mansoura University
Conditions:
Renal Transplant Failure
Eligibility:
All Genders
18-40 years
Phase:
NA
Brief Summary
English Summary And Abstract The overall anesthetic goal for the newly transplanted kidney is to maintain intravascular volume and avoid decreased perfusion by maintaining main arterial blood pressur...
Detailed Description
Material and methods Place of research the Department of Anesthesia and Surgical ICU, Urology and Nephrology Center, Faculty of Medicine, Mansoura University, Mansoura, Egypt. Total duration assumed ...
Eligibility Criteria
Inclusion
- \- Participants with chronic renal failure scheduled for living-related kidney transplantation surgery
Exclusion
- participants with severe left ventricular dysfunction.
- cardiomyopathy with ejection fraction 50%.
- severe anemia (blood hemoglobin Hb5g\\ dL).
- bleeding tendency .
- previously received transplants.
- experienced any surgical complications (e.g., excessive bleeding or resistant graft arterial spasm.
- any surgical difficulty such as the presence of multiple renal vessels.
Key Trial Info
Start Date :
February 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2021
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT03846869
Start Date
February 1 2019
End Date
December 1 2021
Last Update
August 24 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Marwa Ibrahim Mohamed Abdo
Al Mansurah, Egypt